Assessment of clinical, biochemical and radiological profile of SARS COVID-19 patients in a tertiary healthcare hospital and subsequent prediction of prognostic indicators
DOI:
https://doi.org/10.18203/2320-6012.ijrms20223624Keywords:
Mechanical ventilation, Breathlessness, Hypertension, NLR, Haemoglobin, Urea, Creatinine, NT pro BNP, LDHAbstract
Background: To describe the clinical characteristics and outcomes of SARS COVID-19 patients in Karnataka state, India and to evaluate risk factors and laboratory abnormalities leading to adverse outcomes. Radiological chest x-ray features of patients were studied and further elaborated upon.
Methods: A hospital-based, single centre observational prospective study was conducted which included 144 adults with confirmed cases of SARI as per the accepted definition admitted to Kasturba hospital, Manipal in a one-month time frame period who tested positive for the coronavirus. Symptoms taken into consideration were cough, sore throat, breathlessness, and fatigue commonly seen co-morbidities were diabetes, hypertension, IHD and chronic kidney disease. Laboratory variables taken were haemoglobin, CRP, urea, creatinine, NT-Pro BNP and LDH. Final outcome measured was the need for mechanical ventilation which correlates to disease severity. Multivariate logistic regression analysis was done for NLR ratio. Also evaluated was the abnormal radiological appearance of affected patients on chest X-ray describing baseline status and distribution of infiltrates.
Results: Median age of patients was 58 years, 69.4% males (100) and the remaining 30.6% females (44). The mean symptom duration before hospitalization was 3.5 days with a maximum of 30 days and minimum of 1 day. Breathlessness (52.8%) was most commonly seen symptom with almost half (50%) patients having pre-existing hypertension as a co-morbid condition. 46.5% patients had pre-existing diabetes. Abnormal lab values of parameters studied was shown to have a positive association with disease severity. Chi square statistics for decreased haemoglobin was 18.5363, urea-44.6823, creatinine-33.4771, NT PRO BNP-39.812, LDH- 81.3515, with p<0.00001 in all cases. An elevated NLR ratio was found in most patients requiring mechanical ventilation with a significant p<0.05. The 59.7% patients had bilateral lung involvement on CXR with 38.9% showing basal infiltration.
Conclusions: Early detection of laboratory abnormalities in haemoglobin, urea, creatinine, NT pro BNP, LDH and NLR ratio were found to be efficacious in forecasting need for mechanical ventilation in COVID-19 patients and can help better predict patient outcomes to avoid delays in management and care.
References
Aggarwal A, Shrivastava A, Kumar A, Ali A. Clinical and epidemiological features of SARS-CoV-2 patients in SARI ward of a tertiary care centre in New Delhi. J. Assoc. Physicians India 2020;16(8):19-26.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 2020;395(10229):1054-62.
World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance May 27, 2020. https://www.who.int/publications-detail/clinical- management-of-covid-19 (2020).
Zumla A, Hui DS, Perlman S. Middle east respiratory syndrome. Lancet (London, England). 2015;386(9997):995-1007.
Lei H, Li Y, Xiao S, Lin CH, Norris SL, Wei D et al. Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: comparative analyses. Indoor Air. 2018;28(3):394-403.
Minodier L, Charrel RN, Ceccaldi PE, van der Werf S, Blanchon T, Hanslik T et al. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? Virol J. 2015;12(1):215.
Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp. Infect. 2016;92(3):235-50.
Chilimuri S, Sun H, Alemam A, Mantri N, Shehi E, Tejada J et al. Predictors of mortality in adults admitted with COVID-19: retrospective cohort study from New York City. West. J Emerg Med. 2020;21(4):779-84.
Jain SK, Dudani A, Jaiswal N, Deopujari K, Dube SS. Assessment of clinical profile and risk factors associated with adverse outcome in COVID-19 patients at a tertiary care hospital in central India-a retrospective record based study. J Assoc Physicians India. 2021;69(4):27-31.
Matsumoto H, Kasai T, Sato A, Ishiwata S, Yatsu S, Shitara J et al. Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure. Heart Vessels. 2019;34(12):1961-8.
Sharma J, Rajput R, Bhatia M, Arora P, Sood V. Clinical predictors of COVID-19 severity and mortality: a perspective. Front. Cell. Infect. Microbiol. 2021;11:674277.
Milbrandt EB, Reade MC, Lee M, Shook SL, Angus DC, Kong L et al. Prevalence and significance of coagulation abnormalities in community-acquired pneumonia. Mol. Med. 2009;15(11-12):438-45.
Sama IE, Ravera A, Santema BT, van Goor H, Ter Maaten JM, Cleland JGF et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41(19):1810-17.
Velavan TP, Meyer CG. Mild versus severe COVID-19: laboratory markers. Int J Infect Dis. 2020;95:304-7.
Kilercik M, Demirelce Ö, Serdar MA, Mikailova P, Serteser M. A new haematocytometric index: predicting severity and mortality risk value in COVID-19 patients. PLoS One. 2021;16(8):e0254073.
Xia X, Wen M, Zhan S, He J, Chen W. An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19. Nan Fang Yi Ke Da Xue Xue Bao. 2020;40(3):333-6.